Spago Nanomedical AB (publ) (SPAGO.ST)
SEK 0.19
(7.39%)
SEK 0.19
(7.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.2 Million | 1.05 Million | 660 Thousand | 342 Thousand | 30 Thousand | 29.64 Million |
| Cost of Revenue | 24.48 Million | 16.65 Million | 17.43 Million | 758 Thousand | -2.62 Million | -8.64 Million |
| Gross Profit | -23.28 Million | -15.6 Million | -16.77 Million | -416 Thousand | 2.65 Million | 38.28 Million |
| Operating Expenses | 19.79 Million | 23.48 Million | 22.29 Million | 18.53 Million | 22.79 Million | 19.62 Million |
| Selling, General and Administrative Expenses | 24.48 Million | 8.07 Million | 7.54 Million | 5.21 Million | 6.24 Million | 6.82 Million |
| Research and Development Expenses | - | 17.09 Million | 18.81 Million | 3.33 Million | 2.38 Million | 19.82 Million |
| Other Expenses | - | 15.41 Million | 14.74 Million | 13.32 Million | 16.55 Million | 12.8 Million |
| Cost and Expenses | 44.27 Million | 40.13 Million | 39.72 Million | 19.29 Million | 20.17 Million | 10.97 Million |
| Operating Income | -42.5 Million | -39.46 Million | -39.19 Million | -18.96 Million | -20.14 Million | -11.09 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | 112 Thousand | 4000.00 | -25 Thousand | 69 Thousand | -114 Thousand |
| Earnings before Tax | -42.22 Million | -39.19 Million | -39.07 Million | -18.92 Million | -20.21 Million | -11.09 Million |
| Net Income | -42.22 Million | -39.3 Million | -39.07 Million | -18.9 Million | -20.28 Million | -11.09 Million |
| Earnings Per Share Basic | -0.43 | -0.59 | -0.93 | -0.65 | -0.90 | -0.50 |
| Earnings Per Share Diluted | -0.43 | -0.59 | -0.93 | -0.65 | -0.90 | -0.50 |
| Weighted Average Shares Outstanding | 97.97 Million | 66.8 Million | 41.82 Million | 28.99 Million | 22.51 Million | 22.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 97.97 Million | 66.8 Million | 41.82 Million | 28.99 Million | 22.51 Million | 22.06 Million |
| Gross Margin | -19.35 | -14.80 | -25.42 | -1.22 | 88.43 | 1.29 |
| EBIT Margin | -35.10 | -36.74 | -58.62 | -54.36 | -659.50 | -0.36 |
| Profit Margin | -35.10 | -37.30 | -59.20 | -55.27 | -676.00 | -0.37 |
| EBITDA | -42.22 Million | -38.72 Million | -38.69 Million | -18.59 Million | -19.73 Million | -10.71 Million |
| Earnings Before Tax Margin | -35.33 | -37.44 | -59.38 | -55.44 | -671.40 | -0.37 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 459 Thousand | 350 Thousand | 1.2 Million | 731 Thousand | 271 Thousand | 114 Thousand |
| Cost of Revenue | 6.6 Million | 6.26 Million | 23.95 Million | 5.73 Million | 2.49 Million | 2.79 Million |
| Gross Profit | -6.14 Million | -5.91 Million | -22.74 Million | -5 Million | -2.22 Million | -2.68 Million |
| Operating Expenses | 3.54 Million | 3.18 Million | 24.48 Million | 6.23 Million | 5.08 Million | 5.42 Million |
| Selling, General and Administrative Expenses | - | 6.18 Million | - | 5.66 Million | 5.14 Million | 6.84 Million |
| Research and Development Expenses | 3.54 Million | 3.18 Million | - | 6.23 Million | 2.56 Million | 2.86 Million |
| Other Expenses | 5.35 Million | - | - | - | - | - |
| Cost and Expenses | 10.15 Million | 9.44 Million | 48.43 Million | 11.96 Million | 7.58 Million | 8.21 Million |
| Operating Income | -9.69 Million | -9.09 Million | -47.23 Million | -11.23 Million | -7.3 Million | -8.1 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1.00 | 35.72 Thousand | 113.1 Thousand | 32.18 Thousand | -1000.00 | -55.08 Thousand |
| Earnings before Tax | -8.15 Million | -7.76 Million | -42.22 Million | -9.41 Million | -7.11 Million | -7.86 Million |
| Net Income | -8.15 Million | -7.76 Million | -42.22 Million | -9.41 Million | -7.11 Million | -7.86 Million |
| Earnings Per Share Basic | -0.03 | -0.03 | - | -0.08 | -0.07 | -0.08 |
| Earnings Per Share Diluted | -0.03 | -0.03 | - | -0.08 | -0.07 | -0.08 |
| Weighted Average Shares Outstanding | 261.35 Million | 223.34 Million | 97.97 Million | 118.85 Million | 95.21 Million | 95.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 261.35 Million | 223.34 Million | 97.97 Million | 118.85 Million | 95.21 Million | 95.21 Million |
| Gross Margin | -13.39 | -16.89 | -18.91 | -6.85 | -8.20 | -23.51 |
| EBIT Margin | -20.94 | -25.75 | - | -15.27 | -26.71 | -70.49 |
| Profit Margin | -17.76 | -22.18 | -35.10 | -12.88 | -26.25 | -69.00 |
| EBITDA | -9.61 Million | -9.01 Million | - | -11.16 Million | -7.23 Million | -8.03 Million |
| Earnings Before Tax Margin | -21.12 | -25.98 | -39.26 | -15.37 | -26.97 | -71.08 |
PIXY
VIVA
RVLV
SEEK
BMIN4
6796